Exane Derivatives Pimco Corporate & Income Strategy Fund Transaction History

Exane Derivatives

$157 Million
Q2 2022

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 12, 2022	SELL	$12.39 - $16.02 $21,063 - $27,234	-1,700 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$15.2 - $16.37 $326,800 - $351,955	-21,500 Reduced 92.67%	1,700 $26,000
Q2 2020 Jul 10, 2020	SELL	$12.31 - $16.74 $206,808 - $281,232	-16,800 Reduced 42.0%	23,200 $367,000
Q3 2019 Oct 15, 2019	BUY	$16.4 - $18.43 $656,000 - $737,200	40,000 New	40,000 $734,000

Others Institutions Holding PCN

# of Institutions

95

Shares Held

8.93M

Call Options Held

0

Put Options Held

0

Principal Securities, Inc. Des Moines, IA

967K
Shares

$13.2 Million
0.29% of portfolio
Mission Hills Financial Advisory, LLC San Diego, CA

872K
Shares

$11.9 Million
9.08% of portfolio
Morgan Stanley New York, NY

864K
Shares

$11.8 Million
0.0% of portfolio
Guggenheim Capital LLC Chicago, IL

849K
Shares

$11.6 Million
0.09% of portfolio
Northwestern Mutual Wealth Management CO

485K
Shares

$6.6 Million
0.01% of portfolio

About PIMCO CORPORATE & INCOME STRATEGY FUND

Ticker PCN
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
PIMCO Corporate & Income Strategy Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in the fixed income markets of the United States. The fund invests in securities of companies that operate acro...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.